Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jan;63(1):130–133. doi: 10.1038/bjc.1991.26

Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study.

M Tateishi 1, T Ishida 1, T Mitsudomi 1, K Sugimachi 1
PMCID: PMC1971645  PMID: 1989651

Abstract

We examined for transforming growth factor alpha (TGF alpha) in adenocarcinomatous lesions of the lung tissues excised from 138 patients, with use of the avidin-biotin-peroxidase complex (ABC) method. TGF alpha was present in the cytoplasm of the adenocarcinoma. Our objective was to determine if TGF alpha could serve as a prognostic parameter. We divided 138 patients into two groups according to the concentration of TGF alpha. Ninety-two patients had a high concentration of TGF alpha, in over 75% of the tumour cells, while 46 had a low concentration, that is in less than 75% of the cells. The 5-year survival rates of patients with high TGF alpha and low TGF alpha were 39% and 64%, respectively (P less than 0.05). Our data suggest that evidence of a high immunoreactivity of TGF alpha can serve as a prognostic parameter in adenocarcinoma of the lung.

Full text

PDF
130

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett C., Paterson I. M., Corbishley C. M., Luqmani Y. A. Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res. 1989 Apr 15;49(8):2104–2111. [PubMed] [Google Scholar]
  2. Betsholtz C., Bergh J., Bywater M., Pettersson M., Johnsson A., Heldin C. H., Ohlsson R., Knott T. J., Scott J., Bell G. I. Expression of multiple growth factors in a human lung cancer cell line. Int J Cancer. 1987 Apr 15;39(4):502–507. doi: 10.1002/ijc.2910390417. [DOI] [PubMed] [Google Scholar]
  3. Coffey R. J., Jr, Derynck R., Wilcox J. N., Bringman T. S., Goustin A. S., Moses H. L., Pittelkow M. R. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. 1987 Aug 27-Sep 2Nature. 328(6133):817–820. doi: 10.1038/328817a0. [DOI] [PubMed] [Google Scholar]
  4. Coffey R. J., Jr, Goustin A. S., Soderquist A. M., Shipley G. D., Wolfshohl J., Carpenter G., Moses H. L. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res. 1987 Sep 1;47(17):4590–4594. [PubMed] [Google Scholar]
  5. Derynck R., Goeddel D. V., Ullrich A., Gutterman J. U., Williams R. D., Bringman T. S., Berger W. H. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 1987 Feb 1;47(3):707–712. [PubMed] [Google Scholar]
  6. Derynck R., Roberts A. B., Winkler M. E., Chen E. Y., Goeddel D. V. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell. 1984 Aug;38(1):287–297. doi: 10.1016/0092-8674(84)90550-6. [DOI] [PubMed] [Google Scholar]
  7. Hamburger A. W., White C. P., Dunn F. E. Secretion of transforming growth factors by primary human tumour cells. Br J Cancer. 1985 Jan;51(1):9–14. doi: 10.1038/bjc.1985.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hanauske A. R., Arteaga C. L., Clark G. M., Buchok J., Marshall M., Hazarika P., Pardue R. L., Von Hoff D. D. Determination of transforming growth factor activity in effusions from cancer patients. Cancer. 1988 May 1;61(9):1832–1837. doi: 10.1002/1097-0142(19880501)61:9<1832::aid-cncr2820610919>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  10. Lee D. C., Rose T. M., Webb N. R., Todaro G. J. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature. 1985 Feb 7;313(6002):489–491. doi: 10.1038/313489a0. [DOI] [PubMed] [Google Scholar]
  11. Linsley P. S., Hargreaves W. R., Twardzik D. R., Todaro G. J. Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. Proc Natl Acad Sci U S A. 1985 Jan;82(2):356–360. doi: 10.1073/pnas.82.2.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Macias A., Perez R., Hägerström T., Skoog L. Identification of transforming growth factor alpha in human primary breast carcinomas. Anticancer Res. 1987 Nov-Dec;7(6):1271–1275. [PubMed] [Google Scholar]
  13. Madtes D. K., Raines E. W., Sakariassen K. S., Assoian R. K., Sporn M. B., Bell G. I., Ross R. Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell. 1988 Apr 22;53(2):285–293. doi: 10.1016/0092-8674(88)90390-x. [DOI] [PubMed] [Google Scholar]
  14. Marquardt H., Hunkapiller M. W., Hood L. E., Todaro G. J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science. 1984 Mar 9;223(4640):1079–1082. doi: 10.1126/science.6320373. [DOI] [PubMed] [Google Scholar]
  15. Mountain C. F. The biological operability of stage III non-small cell lung cancer. Ann Thorac Surg. 1985 Jul;40(1):60–64. doi: 10.1016/s0003-4975(10)61171-x. [DOI] [PubMed] [Google Scholar]
  16. Nickell K. A., Halper J., Moses H. L. Transforming growth factors in solid human malignant neoplasms. Cancer Res. 1983 May;43(5):1966–1971. [PubMed] [Google Scholar]
  17. Reynolds F. H., Jr, Todaro G. J., Fryling C., Stephenson J. R. Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature. 1981 Jul 16;292(5820):259–262. doi: 10.1038/292259a0. [DOI] [PubMed] [Google Scholar]
  18. Salomon D. S., Zwiebel J. A., Bano M., Losonczy I., Fehnel P., Kidwell W. R. Presence of transforming growth factors in human breast cancer cells. Cancer Res. 1984 Sep;44(9):4069–4077. [PubMed] [Google Scholar]
  19. Sherwin S. A., Twardzik D. R., Bohn W. H., Cockley K. D., Todaro G. J. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res. 1983 Jan;43(1):403–407. [PubMed] [Google Scholar]
  20. Smith J. J., Derynck R., Korc M. Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7567–7570. doi: 10.1073/pnas.84.21.7567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tahara E., Sumiyoshi H., Hata J., Yasui W., Taniyama K., Hayashi T., Nagae S., Sakamoto S. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn J Cancer Res. 1986 Feb;77(2):145–152. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES